Tag: Chemotherapy
Pharmacogenomic Score Can Personalize Treatment of Leukemia in Children
Patients in low ACS10 score group have significantly improved survival with clofarabine+cytarabine treatment
Blinatumomab + Chemo Ups Survival in B-Cell Precursor Acute Lymphoblastic Leukemia
Improved overall survival and three-year relapse-free survival seen with blinatumomab plus chemo for adult patients
Chemo Tied to Gut Microbiome Changes and Associated Cognitive Decline
Findings independent of chemotherapy-induced inflammation
Neuromuscular Training Cuts Onset of Chemo-Induced Peripheral Neuropathy
Incidence of CIPN significantly lower for patients undergoing sensorimotor training, whole-body vibration training
PIK3CA Could Guide Use of COX-2 Inhibitors in Treatment for Colon Cancer
Patients with stage III resected colon cancer with PIK3CA gain-of-function mutations treated with celecoxib had improved DFS, OS
Racial, Ethnic Differences Seen in Breast Cancer Treatment Declination
American Indian, Alaska Native, other; Asian or Pacific Islander; Black patients more likely to decline surgery
Neoadjuvant Chemohormonal Therapy Aids Locally Advanced Prostate Cancer
Significant benefits in terms of three-year biochemical progression-free survival seen for NCHT versus neoadjuvant hormonal therapy
Bilateral Wilms Tumors That Grow During Chemo Mostly Stromal-Predominant
Patients with stromal-predominant tumors had the youngest age at diagnosis compared with other histologic subtypes
AACR: Cadonilimab Plus Chemo Beneficial for Gastric Adenocarcinoma
Improved overall survival, progression-free survival seen, including among patients with low PD-L1 expression
Simple Risk Score Predicts Severe Cisplatin-Linked Acute Kidney Injury
Simple risk score, including nine covariates, predicted risk for CP-AKI in monotonic manner in derivation, validation cohorts
